Launch Date: 18 Jan 2022

Short Description

Adults with normal audiograms and self-reported difficulties comprise more than 12% of the entire American population, yet they are not considered candidates for amplification devices. With the advent of hybrid devices, which combine elements of traditional hearing aids with consumer audio devices, adults with subclinical hearing loss now have access to interventions that improve communication and stave off the ill-effects of other chronic health-related problems.

Part 1 video available now, Part 2 video coming January 31, 2022 to complete CEUs.


 

Created By: Brian Taylor

Long Description:

Adults with normal audiograms and self-reported difficulties comprise more than 12% of the entire American population, yet they are not considered candidates for amplification devices. With the advent of hybrid devices, which combine elements of traditional hearing aids with consumer audio devices, adults with subclinical hearing loss now have access to interventions that improve communication and stave off the ill-effects of other chronic health-related problems.

• Part 1 explores under-served segments of the hearing care market and how Signia’s Active product line could be used to create value for under-served market segments. (AVAILABLE NOW!)
• Part 2. Clinical Implementation and SolutionsPersons with subclinical hearing loss are an untapped market segment. To provide value to this segment, clinicians need to use different clinical tools to measure the functional communication of adults with subclinical hearing loss. Part 2 examines the rationale for earlier intervention and the use of the Quick SIN and validated questionnaires to determine candidacy of the Active and Insio product lines. (AVAILABLE JANUARY 31, 2022)